Residential REIT's

Goldman Sachs is downgrading shares of UDR, Inc. (NYSE: UDR) to Neutral from Buy, but is maintaining its $52 price target. In a note sent to client Goldman writes, "At the start of the year, we had signaled a growing shift in our investment strategy (“2010 Outlook: Rotation into shorter lease term...

UDR, Inc. (NYSE: UDR) announced today that Harry Alcock has joined the company as senior vice president. Mr. Alcock will be responsible for investment activity, including acquisitions, dispositions, redevelopment and asset management in the company's east coast markets. Matt Akin, senior vice...

Analysts at FBR Capital initiate coverage of AvalonBay Communities Inc (NYSE: AVB) with an "outperform" rating. The target price for AVB is set to $128. AVB shares moved down 1.13% to close at $110.48 yesterday. More Analyst Ratings here

Associated Estates Realty Corporation (NYSE: ACE) (NASDAQ: AEC) announced today that a quarterly dividend of $0.17 per share has been declared on the Company's common shares, payable February 1, 2011 to shareholders of record on January 14, 2011.

AvalonBay Communities, Inc. (NYSE: AVB) announced today that its Board of Directors declared a cash dividend on the Company's Common Stock (par value $0.01 per share) for the fourth quarter of 2010. The Common Stock dividend is $0.8925 per share and is payable January 18, 2011 to all Common...

Pfizer Inc. (PFE) recently presented data on its chronic myeloid leukemia (CML) candidate, bosutinib. Results from an ongoing phase III study (BELA - Bosutinib Efficacy and safety in chronic myeloid LeukemiA) showed that bosutinib failed to achieve the primary endpoint of superior complete...

Pfizer Inc. (PFE) recently presented data on its chronic myeloid leukemia (CML) candidate, bosutinib. Results from an ongoing phase III study (BELA - Bosutinib Efficacy and safety in chronic myeloid LeukemiA) showed that bosutinib failed to achieve the primary endpoint of superior complete...

The Board of Trust Managers of Camden Property Trust (NYSE: CPT) declared a fourth quarter cash dividend of $0.45 per share to holders of record as of December 20, 2010 of its Common Shares of Beneficial Interest. The dividend is to be paid on January 18, 2011.

Recently, the US Food and Drug Administration (FDA) extended the review period for potential blockbuster lupus drug candidate, Benlysta, co-developed by Human Genome Sciences Inc. (HGSI) and GlaxoSmithKline plc (GSK), by three months. The US regulatory agency, which was to decide on Benlysta's...

Recently, the US Food and Drug Administration (FDA) extended the review period for potential blockbuster lupus drug candidate, Benlysta, co-developed by Human Genome Sciences Inc. (HGSI) and GlaxoSmithKline plc (GSK), by three months. The US regulatory agency, which was to decide on Benlysta's...

PowerShares introduced four new ETFs based on KBW financial industry indexes on 12/02/2010.  This marks the first time that PowerShares and KBW (Keefe, Bruyette & Woods) have teamed up in the ETF space.  Seven other ETFs based on different KBW indexes are currently on the market under the SPDR...

Mid-America Apartment Communities Inc. (MAA), an apartment-only real estate investment trust (REIT), recently increased its dividend payout by 2% to a quarterly payment of $0.6275 per share or $2.51 on an annualized basis. Mid-America is one of the few companies that has neither reduced nor...

Post Properties Inc. (PPS), a leading operator and developer of multifamily properties across the U.S., has recently announced a new stock and note repurchase program that would replace its existing share repurchase program in place till the end of 2010. Under the terms of the new program, Post...

Mid-America Apartment Communities Inc. (MAA), an apartment-only real estate investment trust (REIT), recently increased its dividend payout by 2% to a quarterly payment of $0.6275 per share or $2.51 on an annualized basis. Mid-America is one of the few companies that has neither reduced nor...